Evidence map›Paper›PMID 27004401›Full record

ArticleOncotarget2016

Protein phosphatase, Mg2+/Mn2+-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection.

Jim Sun, Kaitlyn Schaaf, Alexandra Duverger, Frank Wolschendorf, Alexander Speer, Frederic Wagner, Michael Niederweis, Olaf Kutsch

Abstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. PPM1B utilizes a trinuclear metal architecture for phosphatase activity.bioRxiv : the preprint server for biology · 2026
    Article
  3. Macrophage states and polarization duringFrontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. Article
  6. Multiple CD59 Polymorphisms in Chinese Patients withJournal of immunology research · 2023
    Article
  7. microLife · 2023
    Article
  8. Article
  9. A comprehensive overview of PPM1A: From structure to disease.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  10. Protein phosphatases in TLR signaling.Cell communication and signaling : CCS · 2021
    Review
  11. Article
  12. Frontiers in immunology · 2021
    Article
  13. Article
  14. Knockdown of MgExperimental and therapeutic medicine · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. CD151 Expression Is Associated with a Hyperproliferative T Cell Phenotype.Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jim SunDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kaitlyn SchaafDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Alexandra DuvergerDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Frank WolschendorfDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Alexander SpeerDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Frederic WagnerDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Michael NiederweisDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Olaf KutschDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
The necrosis-inducing toxin of Mycobacterium tuberculosisR01AI121354 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NIEDERWEIS, MICHAEL · 2016 to 2020
$2.5M
HTS for Synergistic Activators of Latent HIV-1 InfectionR01AI104499 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUTSCH, OLAF · 2013 to 2015
$1.6M
HTS for bactericidal inhibitors of M. tuberculosis copper resistance mechanismsR01AI104952 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WOLSCHENDORF, FRANK · 2013 to 2015
$1.1M
Kinomic analysis of host cell factors controlling latent HIV-1 infectionR21AI116188 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUTSCH, OLAF · 2014 to 2015
$551k
NIAID NIH HHS P30 AI027767NIAID NIH HHS R01 AI104499NIAID NIH HHS R01 AI104952NIAID NIH HHS R01 AI121354NIAID NIH HHS R21 AI116188NIAMS NIH HHS P30 AR048311
6 · The paper itself

Abstract

Co-infection with HIV-1 and Mycobacterium tuberculosis (Mtb) is a major public health issue. While some research has described how each pathogen accelerates the course of infection of the other pathogen by compromising the immune system, very little is known about the molecular biology of HIV-1/Mtb co-infection at the host cell level. This is somewhat surprising, as both pathogens are known to replicate and persist in macrophages. We here identify Protein Phosphatase, Mg2+/Mn2+-dependent 1A (PPM1A) as a molecular link between Mtb infection and increased HIV-1 susceptibility of macrophages. We demonstrate that both Mtb and HIV-1 infection induce the expression of PPM1A in primary human monocyte/macrophages and THP-1 cells. Genetic manipulation studies revealed that increased PPMA1 expression rendered THP-1 cells highly susceptible to HIV-1 infection, while depletion of PPM1A rendered them relatively resistant to HIV-1 infection. At the same time, increased PPM1A expression abrogated the ability of THP-1 cells to respond to relevant bacterial stimuli with a proper cytokine/chemokine secretion response, blocked their chemotactic response and impaired their ability to phagocytose bacteria. These data suggest that PPM1A, which had previously been shown to play a role in the antiviral response to Herpes Simplex virus infection, also governs the antibacterial response of macrophages to bacteria, or at least to Mtb infection. PPM1A thus seems to play a central role in the innate immune response of macrophages, implying that host directed therapies targeting PPM1A could be highly beneficial, in particular for HIV/Mtb co-infected patients.

Indexed as

CoinfectionHIV-1HIV InfectionsHumansImmunity, InnateMacrophagesMycobacterium tuberculosisProtein Phosphatase 2CTHP-1 CellsTuberculosisPPM1A protein, humanProtein Phosphatase 2CHIV-1Immune responseImmunityImmunology and Microbiology SectionmacrophagesMycobacterium tuberculosispersistent infectionPPM1A

Identifiers

PMID27004401
PMCPMC4941249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.